RXO RXO, Inc.

NYSE rxo.com


$ 12.90 $ -0.74 (-5.56 %)    

Friday, 07-Nov-2025 19:24:40 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 12.49
$ 13.22
$ 12.35 x 5
$ 14.00 x 7
$ 12.17 - $ 13.24
$ 12.17 - $ 31.11
3,250,151
na
2.05B
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-13-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-03-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 11-30-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-neutral-on-rxo-lowers-price-target-to-15

UBS analyst Thomas Wadewitz maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $17 to $15.

 truist-securities-maintains-buy-on-rxo-lowers-price-target-to-20

Truist Securities analyst Lucas Servera maintains RXO (NYSE:RXO) with a Buy and lowers the price target from $22 to $20.

 barclays-maintains-overweight-on-rxo-lowers-price-target-to-15

Barclays analyst Brandon Oglenski maintains RXO (NYSE:RXO) with a Overweight and lowers the price target from $17 to $15.

 susquehanna-maintains-negative-on-rxo-lowers-price-target-to-10

Susquehanna analyst Bascome Majors maintains RXO (NYSE:RXO) with a Negative and lowers the price target from $11 to $10.

 rxo-q3-adj-eps-001-misses-004-estimate-sales-1421b-miss-1433b-estimate

RXO (NYSE:RXO) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.04 by 72.22 per...

 stifel-maintains-hold-on-rxo-raises-price-target-to-17

Stifel analyst J. Bruce Chan maintains RXO (NYSE:RXO) with a Hold and raises the price target from $14 to $17.

 goldman-sachs-maintains-neutral-on-rxo-lowers-price-target-to-15

Goldman Sachs analyst Jordan Alliger maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $17 to $15.

 jp-morgan-maintains-underweight-on-rxo-raises-price-target-to-16

JP Morgan analyst Brian Ossenbeck maintains RXO (NYSE:RXO) with a Underweight and raises the price target from $15 to $16.

 ubs-maintains-neutral-on-rxo-raises-price-target-to-17

UBS analyst Thomas Wadewitz maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $15 to $17.

 barclays-maintains-overweight-on-rxo-lowers-price-target-to-17

Barclays analyst Brandon Oglenski maintains RXO (NYSE:RXO) with a Overweight and lowers the price target from $18 to $17.

 ubs-maintains-neutral-on-rxo-raises-price-target-to-15

UBS analyst Thomas Wadewitz maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $14 to $15.

 rxo-expects-q3r-2025-adjusted-ebitda-to-be-between-33m-and-43m

Third-Quarter OutlookRXO expects third-quarter 2025 adjusted EBITDA to be between $33 million and $43 million.In Brokerage, the...

 rxo-q2-adj-eps-004-beats-003-estimate-sales-142b-miss-145b-estimate

RXO (NYSE:RXO) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 53.85 perce...

 jp-morgan-maintains-underweight-on-rxo-lowers-price-target-to-14

JP Morgan analyst Brian Ossenbeck maintains RXO (NYSE:RXO) with a Underweight and lowers the price target from $15 to $14.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION